Literature DB >> 24171774

NAD metabolism and functions: a common therapeutic target for neoplastic, metabolic and neurodegenerative diseases.

Giuseppina Di Stefano1, Marcella Manerba, Marina Vettraino.   

Abstract

In recent years the study of nicotinamide adenine dinucleotide (NAD) biochemistry has been the focus of attention for many researchers. Although the role of NAD in cellular metabolism and in redox reactions had been recognized for over a century, it was also during these recent studies that the precise identification of all NAD biosynthetic routes was achieved and that the variety of NAD controlled cellular processes began to emerge. Being vital not only for energy transduction, but also for intracellular signaling pathways, this pyridine nucleotide can be considered the most important link between energetic and regulatory processes. The control of such important events suggested NAD as a possible therapeutic target for the control of different pathological states, including metabolic disorders and neoplastic transformation. This review briefly summarizes the recent advances achieved in this field.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24171774     DOI: 10.2174/15680266113136660207

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  7 in total

1.  Improvement of tissue-specific distribution and biotransformation potential of nicotinamide mononucleotide in combination with ginsenosides or resveratrol.

Authors:  Long-Bo Bai; Lee-Fong Yau; Tian-Tian Tong; Wai-Him Chan; Wei Zhang; Zhi-Hong Jiang
Journal:  Pharmacol Res Perspect       Date:  2022-08

2.  Ginsenoside Rg3 induces apoptosis and inhibits proliferation by down-regulating TIGAR in rats with gastric precancerous lesions.

Authors:  Shangbin Lv; Xiaodong Chen; Yu Chen; Daoyin Gong; Gang Mao; Caifei Shen; Ting Xia; Jing Cheng; Zhaoliang Luo; Yu Cheng; Weihong Li; Jinhao Zeng
Journal:  BMC Complement Med Ther       Date:  2022-07-15

3.  The NAD+ synthesizing enzyme nicotinamide mononucleotide adenylyltransferase 2 (NMNAT-2) is a p53 downstream target.

Authors:  Lu-Zhe Pan; Dae-Gyun Ahn; Tanveer Sharif; Derek Clements; Shashi A Gujar; Patrick W K Lee
Journal:  Cell Cycle       Date:  2014-02-07       Impact factor: 4.534

4.  Stem Cell-Derived Immature Human Dorsal Root Ganglia Neurons to Identify Peripheral Neurotoxicants.

Authors:  Lisa Hoelting; Stefanie Klima; Christiaan Karreman; Marianna Grinberg; Johannes Meisig; Margit Henry; Tamara Rotshteyn; Jörg Rahnenführer; Nils Blüthgen; Agapios Sachinidis; Tanja Waldmann; Marcel Leist
Journal:  Stem Cells Transl Med       Date:  2016-03-01       Impact factor: 6.940

5.  Effective targeting of NAMPT in patient-derived xenograft models of high-risk pediatric acute lymphoblastic leukemia.

Authors:  Klaartje Somers; Kathryn Evans; Richard B Lock; Michelle J Henderson; Leanna Cheung; Mawar Karsa; Tara Pritchard; Angelika Kosciolek; Angelika Bongers; Ali El-Ayoubi; Helen Forgham; Shiloh Middlemiss; Chelsea Mayoh; Luke Jones; Mahima Gupta; Ursula R Kees; Olga Chernova; Lioubov Korotchkina; Andrei V Gudkov; Stephen W Erickson; Beverly Teicher; Malcolm A Smith; Murray D Norris; Michelle Haber
Journal:  Leukemia       Date:  2019-12-17       Impact factor: 12.883

6.  Combined activation of the energy and cellular-defense pathways may explain the potent anti-senescence activity of methylene blue.

Authors:  Hani Atamna; Wafa Atamna; Ghaith Al-Eyd; Gregory Shanower; Joseph M Dhahbi
Journal:  Redox Biol       Date:  2015-09-10       Impact factor: 11.799

7.  Nicotinamide Mononucleotide Adenylyl Transferase 2: A Promising Diagnostic and Therapeutic Target for Colorectal Cancer.

Authors:  Chunhui Cui; Jia Qi; Quanwen Deng; Rihong Chen; Duanyang Zhai; Jinlong Yu
Journal:  Biomed Res Int       Date:  2016-04-27       Impact factor: 3.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.